The Effect of Topical Curcumin Versus Topical Corticosteroid on Management of Oral Lichen Planus Patients
Launched by CAIRO UNIVERSITY · Mar 14, 2019
Trial Information
Current as of May 21, 2025
Unknown status
Keywords
ClinConnect Summary
Two groups will be prepared then decision of which one take curcumin paste will be selected according to randomized numbers in a sequentially numbered, opaque, sealed envelope
1 group will take topical corticosteroid and 1 will take curcumin paste then IL-33 level in saliva will be measured at the base line and at the end of 4th week pain and clinical parameters will be measured at 2nd and 4th week
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who will be clinically diagnosed as having atrophic \&/or erosive oral lichen planus.
- • Patients with controlled diabetes and/or controlled hypertension will be included in the study.
- • Patients with no history of taking corticosteroids for the last 6 months
- • Patients who agrees to take medication.
- Exclusion Criteria:
- • Pregnant and lactating ladies.
- • Patients with history of topical steroids during last 2 months \& systemic steroids during last 6 months.
- • Patients with recent dental filling associated with the lesion or associated with recent drug administration.
- • Patient with uncontrolled diabetes, uncontrolled hypertension, or those with positive HCV ab or HBs Ag.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials